Expansion With IL-15 Increases Cytotoxicity of Vγ9Vδ2 T Cells and Is Associated With Higher Levels of Cytotoxic Molecules and T-bet
Cancer immunotherapy has shown great advances during recent years, but it has yet to reach its full potential in all cancer types. Adoptive cell therapy (ACT) is now an approved treatment option for certain hematological cancers and has also shown success for some solid cancers. Still, benefit and e...
Main Authors: | Pia Aehnlich, Ana Micaela Carnaz Simões, Signe Koggersbøl Skadborg, Gitte Holmen Olofsson, Per thor Straten |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-08-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fimmu.2020.01868/full |
Similar Items
-
Vγ9Vδ2 T Cells Concurrently Kill Cancer Cells and Cross-Present Tumor Antigens
by: Gitte Holmen Olofsson, et al.
Published: (2021-06-01) -
764 Expansion with IL-15 increases cytotoxicity of Vγ9Vδ2 T cells and is associated with higher levels of cytotoxic molecules and T-bet
by: Per thor Straten, et al.
Published: (2020-11-01) -
Chemokine receptor engineering of T cells with CXCR2 improves homing towards subcutaneous human melanomas in xenograft mouse model
by: Manja Idorn, et al.
Published: (2018-08-01) -
Efbalropendekin Alfa enhances human natural killer cell cytotoxicity against tumor cell lines in vitro
by: Hesham M. Shehata, et al.
Published: (2024-03-01) -
Heterodimeric IL-15 in Cancer Immunotherapy
by: Cristina Bergamaschi, et al.
Published: (2021-02-01)